Mangrove Partners’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-930,091
Closed -$11.8M 152
2024
Q1
$11.8M Hold
930,091
0.82% 37
2023
Q4
$10M Hold
930,091
0.68% 48
2023
Q3
$9.93M Hold
930,091
0.75% 46
2023
Q2
$9.57M Hold
930,091
0.66% 47
2023
Q1
$9.71M Sell
930,091
-19,909
-2% -$1.29K 0.64% 43
2022
Q4
$9.69M Buy
+950,000
New +$44.1K 0.55% 46

Other funds holding SBCWW

Mangrove Partners's SBCWW Position: Q2 2024 in Review

Mangrove Partners sold out of SBC Medical Group Warrants (SBCWW) in Q2 2024, closing a stake of 930,091 shares — an estimated $11.8M sold.

Mangrove Partners first reported a position in SBCWW in Q4 2022 and held it in 6 quarters. The position peaked at $11.8M in Q1 2024. 29 funds tracked by Wall St. Rank hold SBCWW as of Q2 2024.

  • Mangrove Partners reported no remaining SBC Medical Group Warrants position as of Q2 2024 after selling out during the quarter.
  • Mangrove Partners sold 930,091 SBC Medical Group Warrants shares in Q2 2024, an estimated $11.8M.
  • Mangrove Partners first reported a position in SBC Medical Group Warrants in Q4 2022 and held it in 6 quarters.
  • Mangrove Partners's SBC Medical Group Warrants position peaked at $11.8M in Q1 2024.
  • 29 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q2 2024.

Based on Mangrove Partners's 13F filing for Q2 2024, filed 14 Aug 2024.